Stockscreener 앱 받기
22.85
0.57%
-0.13
전일 마감가:
$22.98
열려 있는:
$22.54
하루 거래량:
295.51K
Relative Volume:
0.93
시가총액:
$1.33B
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
-6.47%
1개월 성능:
-15.37%
6개월 성능:
+48.86%
1년 성능:
+0.00%
1일 변동 폭
$22.16
$23.16
1주일 범위
$21.37
$24.39
52주 변동 폭
$13.25
$30.00
Kestra Medical Technologies Ltd Stock (KMTS) Company Profile
명칭
Kestra Medical Technologies Ltd
전화
(425) 279-8002
주소
3933 LAKE WASHINGTON BLVD NE, KIRKLAND
KMTS을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
KMTS
Kestra Medical Technologies Ltd
|
22.85 | 1.34B | 0 | 0 | 0 | 0.00 |
|
ISRG
Intuitive Surgical Inc
|
535.00 | 191.90B | 9.61B | 2.77B | 2.27B | 7.555 |
|
BDX
Becton Dickinson Co
|
207.11 | 59.36B | 21.84B | 1.68B | 2.67B | 5.8293 |
|
ALC
Alcon Inc
|
79.00 | 39.13B | 10.19B | 1.05B | 1.38B | 2.1044 |
|
RMD
Resmed Inc
|
257.58 | 38.05B | 5.26B | 1.44B | 1.76B | 9.7713 |
|
MDLN
Medline Inc
|
44.12 | 33.62B | 27.43B | 1.27B | 1.01B | 1.5829 |
Kestra Medical Technologies Ltd Stock (KMTS) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-11-18 | 개시 | BTIG Research | Buy |
| 2025-03-31 | 개시 | BofA Securities | Buy |
| 2025-03-31 | 개시 | Goldman | Neutral |
| 2025-03-31 | 개시 | Piper Sandler | Overweight |
| 2025-03-31 | 개시 | Stifel | Buy |
| 2025-03-31 | 개시 | Wells Fargo | Overweight |
| 2025-03-31 | 개시 | Wolfe Research | Outperform |
모두보기
Kestra Medical Technologies Ltd 주식(KMTS)의 최신 뉴스
Institutions along with private equity firms who hold considerable shares inKestra Medical Technologies, Ltd. (NASDAQ:KMTS) come under pressure; lose 6.5% of holdings value - Yahoo Finance UK
Analysts Offer Insights on Healthcare Companies: Solventum Corporation (SOLV) and Praxis Precision Medicines (PRAX) - The Globe and Mail
KMTS, Biobeat Partner to Expand Diagnostic Insight in Cardiac Recovery - TradingView — Track All Markets
Kestra Medical partners with Biobeat to add blood pressure monitoring By Investing.com - Investing.com Nigeria
KMTS: Strong clinical data and innovation drive rapid growth and margin expansion in the WCD market - TradingView — Track All Markets
Kestra Medical partners with Biobeat to add blood pressure monitoring - Investing.com
72% of heart recovery patients are hypertensive in Kestra BP tech deal - Stock Titan
Kestra Medical Technologies (KMTS) Stock Analysis: Exploring a 25.71% Upside Potential in the Healthcare Sector - DirectorsTalk Interviews
Market Rankings: Will Kestra Medical Technologies Ltd outperform its industry peersPortfolio Performance Summary & Fast Gain Swing Trade Alerts - baoquankhu1.vn
Kestra Medical Technologies (NASDAQ:KMTS) Trading Down 6% – What’s Next? - Defense World
Goldman Sachs Maintains Kestra Medical Technologies(KMTS.US) With Hold Rating, Raises Target Price to $27 - 富途牛牛
Kestra Medical Technologies (NASDAQ:KMTS) Stock Price Down 6%Time to Sell? - MarketBeat
Is Kestra Medical Technologies Ltd. stock positioned for long term growthEarnings Risk Report & Weekly Hot Stock Watchlists - ulpravda.ru
Will Kestra Medical Technologies Ltd. stock return to pre crisis levelsJuly 2025 Highlights & Long-Term Capital Growth Strategies - Улправда
Kestra Medical Technologies (NASDAQ:KMTS) Stock Price Down 6.1% – Here’s Why - Defense World
Kestra Medical Technologies (NASDAQ:KMTS) Trading Down 6.1%Here's What Happened - MarketBeat
Traci Umberger Sells 10,500 Shares of Kestra Medical Technologies (NASDAQ:KMTS) Stock - Defense World
Kestra Medical Technologies, Ltd. (NASDAQ:KMTS) Given Consensus Recommendation of “Moderate Buy” by Brokerages - Defense World
Webster, Kestra medical CEO, sells $398k in shares By Investing.com - Investing.com Australia
Insider Selling: Kestra Medical Technologies (NASDAQ:KMTS) Insider Sells 10,500 Shares of Stock - MarketBeat
Kestra Medical Technologies Insider Sold Shares Worth $280,201, According to a Recent SEC Filing - marketscreener.com
Kestra Medical Technologies Insider Sold Shares Worth $398,847, According to a Recent SEC Filing - marketscreener.com
Kestra Medical Technologies, Ltd. (NASDAQ:KMTS) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Kestra Medical Technologies to Present at the 44th Annual J.P. Morgan Healthcare Conference - The Manila Times
Both Private Equity Firms Who Control a Good Portion of Kestra Medical Technologies, Ltd. (NASDAQ:KMTS) Along With Institutions Must Be Dismayed After Last Week's 3.1% Decrease - 富途牛牛
Biobeat Technologies Ltd. announced that it has received $50 million in funding from Ally Bridge Group, OrbiMed Advisors LLC, Elevage Medical Technologies, Kestra Medical Technologies, Ltd. and other investors - marketscreener.com
Kestra Medical Technologies Ltd (KMTS) is an excellent investment, but the stock is overvalued/undervalued right now - uspostnews.com
Can Kestra Medical Technologies Ltd. stock maintain operating margins2025 Volume Leaders & AI Driven Stock Reports - Улправда
Will Kestra Medical Technologies Ltd. stock benefit from AI adoptionJuly 2025 Weekly Recap & Risk Controlled Swing Alerts - Улправда
Kestra Medical Technologies sees Q2 revenue between $22.2M and $22.6M - MSN
Is Kestra Medical Technologies (KMTS) Overvalued After Its Recent Share Price Climb? - Sahm
Kestra Medical prices upsized $138M offering - MSN
Kestra Medical Technologies reports strong earnings growth - MSN
Kestra Medical Technologies (NASDAQ:KMTS) Shares Gap UpHere's What Happened - MarketBeat
Kestra Medical Technologies (KMTS) Q2: Revenue Growth, Losses Deepen, Testing Bullish Scale Narratives - Sahm
Wells Fargo Maintains Kestra Medical Technologies (KMTS) Overweight Recommendation - Nasdaq
Kestra Medical Technologies’ revenue up 53% to USD 22.6M in Q2 FY26 - Medical Buyer
Kestra Medical Technologies, Ltd. $KMTS Position Increased by Eventide Asset Management LLC - MarketBeat
Kestra Medical Technologies Reports Strong Earnings Growth - TipRanks
Wells Fargo Raises Price Target for KMTS, Maintains Overweight R - GuruFocus
Kestra Medical price target raised to $30 from $27 at Piper Sandler - MSN
Kestra Medical Technologies stock price target raised by Stifel to $30 - Investing.com Australia
Kestra Medical Technologies stock price target raised to $30 from $27 at Piper Sandler By Investing.com - Investing.com South Africa
Kestra Medical Technologies stock price target raised to $30 from $27 at Piper Sandler - Investing.com Australia
Kestra Medical Technologies: Strong Financial Performance and Market Leadership Drive Buy Rating - TipRanks
Kestra raises FY26 revenue guidance to $91M while targeting 70%+ gross margins with ASSURE system expansion - MSN
Is Kestra Medical Technologies Ltd a good long term investmentSector Performance Drivers & High Return Trading Strategies - earlytimes.in
Kestra Medical Technologies Ltd (KMTS) Q2 2026 Earnings Call Highlights: Revenue Surge and ... By GuruFocus - Investing.com Canada
Earnings call transcript: Kestra Medical Technologies Q2 2025 shows strong revenue growth By Investing.com - Investing.com South Africa
Earnings call transcript: Kestra Medical Technologies Q2 2025 shows strong revenue growth - Investing.com Australia
Kestra Medical raises FY26 revenue view to $91M from $88M, consensus $88.02M - TipRanks
Kestra Medical Technologies Ltd (KMTS) 재무 분석
Kestra Medical Technologies Ltd (KMTS)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
Kestra Medical Technologies Ltd 주식 (KMTS) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Umberger Traci S | See Remarks |
Dec 29 '25 |
Sale |
26.69 |
10,500 |
280,201 |
136,633 |
| Webster Brian Daniel | See Remarks |
Dec 29 '25 |
Sale |
26.59 |
15,000 |
398,847 |
409,786 |
0.01%
1.19%
자본화:
|
볼륨(24시간):